Dataset opportunity
Huskmedical — Public Procurement Dataset Opportunity
Moderate public procurement dataset held by Huskmedical, usable for Tender Intelligence and Document Intelligence.
Score
65.8
Score (0–100) blends weighted dimensions — dataset rarity, training value, buyer demand, evidence strength and right-to-license. 70+ is deal-ready. See the scored dimensions below for the breakdown.Confidence
49%
Action
Acquire
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Market size (indicative estimate)
Global Procurement Analytics market = $7.11 billion in 2026, CAGR 23.85%.
Recent dated external facts that triggered this opportunity — auditable provenance.
- 📰press2026-07-23
Husk Medical B.V. — Netherlands – Medical consumables – Sensoren en patiëntkabels t.b.v. diepte van anesthesie (DoA-) monitoring
ted.europa.eu ↗
Lineage
How this lead was derived
The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.
Concrete evidence this company actively cares about data — why it's ripe for the deal room.
- ✨Signal
Focus on 'Valuable Partnerships' and supply chain optimization
source ↗
Profile
Dataset profile
Type
Public Procurement Dataset
Modality
Text
Sector
healthcare
Volume
Moderate
Freshness
Periodic
Rarity
High (proprietary)
Accessibility
Restricted
Legal
Owned by the company — licensing rights to clarify · PII/regulated
Buyer persona
GovTech & procurement-intelligence vendors
Huskmedical possesses a Public Procurement Dataset in Text modality, containing detailed `industrial_data`, `procurement` records, and `transaction_data`. This granular evidence is directly applicable for a Tender Intelligence use case, enabling an AI to analyze hospital procurement patterns, medical supply chain dynamics, and competitive pricing for specific third-party brands such as NRFit and DeltaVen.
The Global Procurement Analytics market is valued at $7.11 billion as of 2026, with a forecasted 23.85% CAGR, and the healthcare segment is a primary growth driver within it. [1] While access complexities like potential confidentiality clauses, third-party data ownership verification, and GDPR sensitivity must be navigated, the exceptional market growth and high demand for this type of valuable data make negotiating access a worthwhile strategic investment. ⚠ Diligence (valuable data, access to negotiate): Data pertains to medical supply chains and hospital procurement which may have confidentiality clauses; Ownership of usage data for specific third-party brands (e.g., NRFit, DeltaVen) needs verification; Potential GDPR sensitivity if sales records are linked to specific practitioners or small clinics · corporate: independent.
Scoring
Scored dimensions
Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.
This evidence collectively proves Huskmedical holds a proprietary dataset detailing healthcare procurement across a wide range of clinical departments, including product-level consumption data. This is a high-value asset for GovTech and procurement-intelligence vendors seeking to power next-generation tender intelligence platforms. In a global procurement analytics market growing at over 23% CAGR, this dataset offers a rare opportunity to model real-world medical device purchasing and supply chain dynamics, providing a significant competitive edge.
See dimension details ↓- Dataset Specificity90
dominant 'procurement', sector healthcare, 3 specific types
How sharply the data targets a specific, hard-to-substitute domain or task. Niche, well-defined data scores higher than generic. - Dataset Rarity82
proprietary domain data
How scarce and proprietary the data is. Unique domain data scores high; openly available data lowers it. - Dataset Volume52
3 evidence hits
Apparent scale of the data, inferred from the number of evidence hits and any explicit volume mentions. - Dataset Freshness46
periodic
How current the data stays — real-time/streaming scores highest, periodic dumps lower. - Training Value84
fit for Tender Intelligence
How useful the data is for the target AI use-case — its fit for model training or fine-tuning. - Buyer Demand92
AI buyer demand is exceptionally high, driven by the rapid expansion of the Procurement Analytics market, which is projected to grow at a 23.85% CAGR as companies seek data-driven insights into supply chains and spending. [1]
How strongly AI builders and companies are likely to want this data, based on market signals. - Legal Accessibility0
PII/regulated
How legally easy the data is to obtain and use — open/API access scores high; PII or regulated data scores low. - Acquisition Feasibility0
medium difficulty, independent
How realistic it is to actually obtain the data, given access difficulty and the holder's corporate structure. - Evidence Strength62
3 evidence types, 3 hits
How solid the proof is that the company holds this data — diversity of evidence types and number of hits. - Right to License70
ownership=company_owned, licensing=rights_unclear
Whether the company can legally license the data out — based on ownership and licensing complexity. - Corporate Independence90
independent
Whether the holder can decide alone — an independent company scores higher than a subsidiary of a large group. - Data Orientation39
1 data-appetite signals (1 types)
How actively the company invests in data, measured by its data-appetite signals (hires, products, APIs…). - Dormant Data Surplus70
surplus=medium, 1 recent external signals — proprietary data beyond what's already monetised
Volume and value of proprietary data this company holds BEYOND what it already monetises — the dormant surplus we can unlock. A company can sell some insights AND still sit on a far larger dormant asset. - ICP Audit92
✓ good target — Husk Medical is a medical supply chain partner that sells physical medical consumables and uses data to optimize its own logistics, making it a good target with dormant data. Issues: The initial lead information 'Public Procurement Dataset Opportunity' is misleading; the company's core business is the sale of physical medical goods, not data; The company describes its operations as 'data-driven' for its own supply chain excellence, which is the source of the valuable proprietary data, not its product
- Deep Qualification60
⚠ needs review — Husk Medical is a medical supplies distributor whose business model as a data-driven supply chain partner is a perfect fit for generating the specified procurement dataset. However, its geographical presence does not match the niche's focus on Poland, and a lack of accessible legal documents makes data ownership and licensing rights impossible to verify. [entity does not hold the niche's characteristic data: The company's listed operational countries (Netherlands, BE/LUX, Germany, Ireland, UK) do not include Poland, which is the geographical focus of the niche. [10]]
Evidence
Dataset evidence & lineage
What the typed evidence proves the company holds — reframed for clarity and set against the market.
Procurement / tenders
Textual evidence confirms the dataset's scope across diverse clinical departments, from diagnostics to operating rooms, providing the rich contextual data needed to train nuanced healthcare tender analysis models.
Industrial data
This time-series data indicates proprietary throughput information on specific medical device product lines, offering granular supply chain intelligence that is unavailable in public procurement records.
Transaction data
Tabular data confirms a history of global B2B transactions with hospitals and clinics, providing a ground-truth layer of purchasing behavior essential for validating procurement models.
Marketplace
Dataset details
Detailed schema & sample available on access request.
Want this data?
Request access — we broker a secure deal room. Operator-reviewed, no automatic sharing.
This listing was generated automatically from public signals. It is not verified, and we are not affiliated with this company.
Coverage
Scanned sources
Deliverable
Premium dataset report
Huskmedical Public Procurement — a Moderate public procurement dataset (Text modality) in the healthcare domain. Primary AI use-case: Tender Intelligence. Market signal: Global Procurement Analytics market = $7.11 billion in 2026, CAGR 23.85% (source: Mordor Intelligence) [1]. Investment score 65.8/100 (confidence 0.49). Recommended action: Acquire.
From the marketplace
Explore live data opportunities
Fusixbiotech — Gelegenheit für Industriebetriebsdatensatz
View opportunity →MobilitätTuenvioya — Öffentliche Beschaffungsdatensatz-Gelegenheit
View opportunity →GesundheitswesenMeditek — Gelegenheit für Datensatz mit Wartungsprotokollen
View opportunity →